Pulmatrix, Inc. (PULM)
NASDAQ: PULM · Real-Time Price · USD
1.440
+0.007 (0.49%)
At close: Sep 18, 2026, 4:00 PM EDT
1.440
0.00 (0.01%)
After-hours: Sep 18, 2026, 6:39 PM EDT
Pulmatrix Market Cap
Pulmatrix has a market cap or net worth of $5.26 million as of September 18, 2026. Its market cap has decreased by -70.55% in one year.
Market Cap
5.26M
Enterprise Value
3.09M
1-Year Change
-70.55%
Ranking
Category
Stock Price
$1.44
ChartMarket Cap Chart
Since June 16, 2015, Pulmatrix's market cap has decreased from $165.85M to $5.26M, a decrease of -96.83%. That is a compound annual growth rate of -26.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 5.26M | -35.43% |
| Dec 31, 2025 | 8.14M | -68.05% |
| Dec 31, 2024 | 25.49M | 275.27% |
| Dec 29, 2023 | 6.79M | -51.89% |
| Dec 30, 2022 | 14.12M | -42.64% |
| Dec 31, 2021 | 24.61M | -39.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Creative Medical Technology Holdings | 6.37M |
| AIM ImmunoTech | 6.32M |
| Ernexa Therapeutics | 6.25M |
| Cardio Diagnostics Holdings | 5.98M |
| Kairos Pharma | 5.86M |
| NuCana | 5.77M |
| Lexaria Bioscience | 5.35M |
| Can-Fite BioPharma | 4.95M |